Nuvei adds payment solution for nearly 40 cryptocurrencies

Nuvei adds payment solution for nearly 40 cryptocurrencies
MONTREAL –  Nuvei Corporation (TSX: NVEI and NVEI.U), the global payment technology partner of thriving brands, reported it has added pay-in and payout support for nearly 40 of the world’s leading cryptocurrencies, including Bitcoin, Ethereum, Bitcoin Cash, Litecoin, NEO, Ripple and more. Now, eCommerce merchants can join the cryptocurrency revolution, offering innovative payment methods to access more customers around the... Read More

Mining sector needs to get in on the hunt for strategic minerals

Mining sector needs to get in on the hunt for strategic minerals
Local access to these strategic minerals is crucial if we are to ensure the long-term viability of our technology sector The Canadian mining sector has been a vital cog in the country’s economy during the pandemic, with the importance of the industry growing steadily over time. Operations and exploration continued during the COVID-19 outbreak, collaborations with Indigenous communities expanded, technological... Read More

Bragg Gaming announces intent to list on the Nasdaq

Bragg Gaming announces intent to list on the Nasdaq
TORONTO – B2B gaming technology platform provider Bragg Gaming Group (TSX: BRAG, OTC: BRGGF) announced today that the Company has filed an application to list its common shares on the Nasdaq Stock Market. In connection with today’s mailing of the Company’s management information circular for its Annual General and Special Shareholders Meeting, Bragg is seeking authorization from shareholders to grant the board... Read More

BetterLife added to Horizons Psychedelic Stock Index ETF

BetterLife added to Horizons Psychedelic Stock Index ETF
VANCOUVER – BetterLife Pharma Inc. (CSE: BETR / OTCQB: BETRF / FRA: NPAU) has been added to the Horizons Psychedelic Stock Index ETF (PSYK: NEO), the world’s first ETF offering direct exposure to North American publicly listed securities that have significant business activities in, or significant exposure to, the psychedelics industry. BetterLife’s therapeutic pipeline includes TD-0148A, a nontoxic second-generation Lysergic... Read More

Psirenity to conduct Jamaica’s first psilocybin clinical trial to manage depression

Psirenity to conduct Jamaica’s first psilocybin clinical trial to manage depression
  TORONTO – Psirenity, a wholly-owned subsidiary of New Leaf Canada Inc., reported it has received approval to conduct the first clinical trial protocol with psilocybin in Jamaica.  Psirenity is emerging as a leader in science-backed brain health and wellness. Its focus is on providing holistic treatments that help solve today’s mental health pandemic by expanding its own understanding and the world’s acceptance of advanced psychedelic-enhanced mental health solutions, while accelerating patient intake... Read More